1299 related articles for article (PubMed ID: 23676191)
1. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.
Geraghty PJ; Mewissen MW; Jaff MR; Ansel GM;
J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191
[TBL] [Abstract][Full Text] [Related]
2. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Pearl G; Theune B; Black S
J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
[TBL] [Abstract][Full Text] [Related]
3. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Hohman S; Pearl G; Theune B
J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
[TBL] [Abstract][Full Text] [Related]
5. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.
Zeller T; Peeters P; Bosiers M; Lammer J; Brechtel K; Scheinert D; Rastan A; Noory E; Beschorner U
J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT
J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.
Ohki T; Kichikawa K; Yokoi H; Uematsu M; Yamaoka T; Maeda K; Kanaoka Y
J Vasc Surg; 2017 Jul; 66(1):130-142.e1. PubMed ID: 28400218
[TBL] [Abstract][Full Text] [Related]
8. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis.
Kawamura Y; Ishii H; Aoyama T; Tanaka M; Takahashi H; Kumada Y; Toriyama T; Murohara T
J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527
[TBL] [Abstract][Full Text] [Related]
9. The role of superficial femoral artery endoluminal bypass in long de novo lesions and in-stent restenosis.
Doomernik DE; Golchehr B; Lensvelt MM; Reijnen MM
J Cardiovasc Surg (Torino); 2012 Aug; 53(4):447-57. PubMed ID: 22854524
[TBL] [Abstract][Full Text] [Related]
10. Evolving modalities for femoropopliteal interventions.
Ansel GM; Lumsden AB
J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II82-97. PubMed ID: 19624076
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of the Japanese multicenter Viabahn trial of heparin bonded endovascular stent grafts for long and complex lesions in the superficial femoral artery.
Ohki T; Kichikawa K; Yokoi H; Iida O; Yamaoka T; Maeda K; Kanaoka Y
J Vasc Surg; 2021 Dec; 74(6):1958-1967.e2. PubMed ID: 34182032
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of covered stent placement for central venous occlusive disease in hemodialysis patients.
Anaya-Ayala JE; Smolock CJ; Colvard BD; Naoum JJ; Bismuth J; Lumsden AB; Davies MG; Peden EK
J Vasc Surg; 2011 Sep; 54(3):754-9. PubMed ID: 21664095
[TBL] [Abstract][Full Text] [Related]
13. The role of stent-grafts for prevention and treatment of restenosis.
Kwa AT; Yeo KK; Laird JR
J Cardiovasc Surg (Torino); 2010 Aug; 51(4):579-89. PubMed ID: 20671643
[TBL] [Abstract][Full Text] [Related]
14. Outcome of thrombolysis and thrombectomy for thrombosed endografts inserted in the superficial femoral artery for occlusive disease.
Golchehr B; Lensvelt MM; Fritschy WM; Holewijn S; van Walraven LA; van Oostayen JA; Zeebregts CJ; Reijnen MM
J Endovasc Ther; 2013 Dec; 20(6):836-43. PubMed ID: 24325702
[TBL] [Abstract][Full Text] [Related]
15. Performance of ePTFE-covered endograft in patients with occlusive disease of the superficial femoral artery: a three-year clinical follow-up study.
Fritschy WM; Kruse RR; Frakking TG; Van Geloven AA; Blomme AM
J Cardiovasc Surg (Torino); 2010 Dec; 51(6):783-90. PubMed ID: 21124274
[TBL] [Abstract][Full Text] [Related]
16. Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease.
Schneider JR; Verta MJ; Alonzo MJ; Hahn D; Patel NH; Kim S
Vasc Endovascular Surg; 2011 Jul; 45(5):391-7. PubMed ID: 21669863
[TBL] [Abstract][Full Text] [Related]
17. Results of polytetrafluoroethylene-covered nitinol stents crossing the inguinal ligament.
Calligaro KD; Balraj P; Moudgill N; Rao A; Dougherty MJ; Eisenberg J
J Vasc Surg; 2013 Feb; 57(2):421-6. PubMed ID: 23058723
[TBL] [Abstract][Full Text] [Related]
18. Is there an alternative to the surgical above-knee bypass in treatment of superficial femoral artery disease? Experiences with Viabahn stent graft.
Jebran AF; Popov AF; Zenker D; Bireta C; Friedrich M; Danner BC; Bougioukas I; Schoendube FA; Stojanovic T
Vasc Endovascular Surg; 2013 Oct; 47(7):502-6. PubMed ID: 23867203
[TBL] [Abstract][Full Text] [Related]
19. Viabahn Stent Graft for the Endovascular Treatment of Occlusive Lesions in the Femoropopliteal Artery: A Retrospective Cohort Study with 4-Year Follow-Up.
Ni Q; Yang S; Xue G; Zhou Z; Zhang L; Ye M
Ann Vasc Surg; 2020 Jul; 66():573-579. PubMed ID: 31743785
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of endovascular treatment of TASC-II C and D femoropopliteal lesions with the Viabahn endoprosthesis.
Mohr PJ; Oyama JK; Luu JT; Stinis CT
Cardiovasc Revasc Med; 2015 Dec; 16(8):465-8. PubMed ID: 26483319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
